Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-05-22

Clinical Trial Update: Erythropoietin Spinal Cord Compression Randomized Trial [Phase 2, Phase 3]

View source ↗

Summary

A randomized Phase 2/3 trial evaluating erythropoietin for spinal cord compression was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Erythropoietin (erythropoietin)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Nerve Compression Syndromes | Phase 2, Phase 3 | Status: TERMINATED